Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11 - Wikidata - awgldk - TriplyDB

Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11

Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11

http://www.wikidata.org/entity/Q35249810

about

Interaction of the Oncofetal Thomsen-Friedenreich Antigen with Galectins in Cancer Progression and Metastasis Targeting tumor-stromal interactions in bone metastasis Development and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progression Computational Screening of the Human TF-Glycome Provides a Structural Definition for the Specificity of Anti-Tumor Antibody JAA-F11 Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface Expression of MUC1 and CD176 (Thomsen-Friedenreich antigen) in papillary thyroid carcinomas Neoplasia: Where We Have Been and Where We Are Going Neoplasia: the second decade.Presentation, presentation, presentation! Molecular-level insight into linker effects on glycan array screening data.Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen.In vivo tumor cell adhesion in the pulmonary microvasculature is exclusively mediated by tumor cell--endothelial cell interaction.Endothelial integrin α3β1 stabilizes carbohydrate-mediated tumor/endothelial cell adhesion and induces macromolecular signaling complex formation at the endothelial cell membrane.Protein modifications as potential biomarkers in breast cancer.Monoclonal antibody 4C5 prevents activation of MMP2 and MMP9 by disrupting their interaction with extracellular HSP90 and inhibits formation of metastatic breast cancer cell deposits.The "inherent vice" in the anti-angiogenic theory may cause the highly metastatic cancer to spread more aggressively.The 4C5 cell-impermeable anti-HSP90 antibody with anti-cancer activity, is composed of a single light chain dimer Tumour-associated carbohydrate antigens in breast cancer.Increased sialylation of anti-Thomsen-Friedenreich antigen (CD176) antibodies in patients with gastric cancer: a diagnostic and prognostic potential Detection of breast cancer cells in blood samples by immunostaining of the Thomsen-Friedenreich antigen.The Thomsen-Friedenreich antigen-binding lectin jacalin interacts with desmoglein-1 and abrogates the pathogenicity of pemphigus foliaceus autoantibodies in vivo.Tumor immunolocalization using 124 I-iodine-labeled JAA-F11 antibody to Thomsen-Friedenreich alpha-linked antigen Direct targeted glycation of the free sulfhydryl group of cysteine residue (Cys-34) of BSA. Mapping of the glycation sites of the anti-tumor Thomsen-Friedenreich neoglycoconjugate vaccine prepared by Michael addition reaction.Cancer vaccines and carbohydrate epitopes.Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-L-leucine.Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia.Inoculated Cell Density as a Determinant Factor of the Growth Dynamics and Metastatic Efficiency of a Breast Cancer Murine Model Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines Increased Avidity of the Sambucus nigra Lectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric Cancer.Jaa-f11: extending the life of mice with breast cancer.Aberrant glycosylation of the anti-Thomsen-Friedenreich glycotope immunoglobulin G in gastric cancer patients.A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell-lymphatic endothelium interaction Synthesis of the tumor associative α-aminooxy disaccharide of the TF antigen and its conjugation to a polysaccharide immune stimulant.Galectins as new prognostic markers and potential therapeutic targets for advanced prostate cancers.Anti-idiotypic antibody mimicking a T-antigen-specific lectin inhibits human epithelial tumor cell proliferation.Synthesis and Evaluation of Glycoconjugates Comprising N-Acyl-Modified Thomsen-Friedenreich Antigens as Anticancer Vaccines.Micro and Nano Material Carriers for Immunomodulation.Preclinical studies with JAA-F11 anti-Thomsen-Friedenreich monoclonal antibody for human breast cancer.Tagging staphylococcal enterotoxin B (SEB) with TGFaL3 for breast cancer therapy.Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis.Inhibition of Hypoxia-Induced Cell Motility by p16 in MDA-MB-231 Breast Cancer Cells.

P2860

Q26749378-ADEDB6C7-422F-4228-BE99-7A239B26B1CA Q27024561-1B821DB6-91D0-4857-B82D-B93D634E0396 Q27325140-C897761E-39CA-4FB8-B8B2-4AD8FABB66EF Q27676091-1B8741C9-BB86-4C0C-9514-B7E099AD6724 Q28255527-899F9207-A2FD-4031-90FB-E8B71B3F4F50 Q28255822-573DE7B7-83DB-477E-9EF6-0074B1579DC2 Q28395095-1087E3D5-4139-47E4-BAF6-BD41CD381B64 Q30484000-3D70C4F6-443F-430E-BA7C-B6D0B04842DD Q30668797-EA4FF68A-5C33-4A4F-9064-9C756532F5D6 Q33489506-8AAA93CD-5735-44F3-9F11-340D2BC3A642 Q33569192-3F6F7D48-7156-4683-92BA-3A7CBF77455A Q33576873-6FEA2767-BE2E-4D52-97AC-85AD2494C958 Q33586407-17DA17EC-A0A2-475C-AFDE-C10FB807C612 Q33625373-8626D211-F2F9-4FDC-A710-25481AA9AC61 Q33725650-867DE5DA-7462-4AF0-9DF6-16DEF24F2F4D Q34017774-B0566D59-10C3-4D63-A295-906EF36B8D1A Q34048052-B544E55D-7C3F-4480-8EC9-20B24D012BD4 Q34208137-7964D6F0-850E-425B-B0E2-92E73495336B Q34707461-BC7517A4-0931-422C-886D-5FCEDF7E98C9 Q35180299-87337856-0411-48D9-B17F-6F40A262DE00 Q35334908-AAED66AA-76DE-4038-9636-03C49A69EF14 Q35492743-29E52E7C-E9FE-4CF2-BF9F-691216F1BD07 Q35525289-BA73FA5D-4AF7-4E72-9888-2056632CF0A9 Q35763903-6D12322D-1ED3-48A5-BAFC-4AC166E283B1 Q35945071-19557D0C-B7C2-4BA8-B2CC-0603285ECB83 Q36184480-14E4CB72-D551-46B2-8F0B-BA9E8C91B320 Q36200540-6F471CE0-DFCD-4A8A-A21D-2EF77CD2ABBD Q36339643-C759BC64-FD1F-4D89-B175-28D105ED6353 Q36897363-4DF351BE-583E-4238-863C-3D141437D9E0 Q36950893-EAC01CAF-3E0A-40B2-B391-BB93591BAA3D Q37328722-7DCB983B-21F8-4E62-8D69-C2C63AF7FD07 Q37642032-69C5AFC0-7891-48C8-AAC9-240A2F4230C7 Q38160862-28D55ADA-1B5B-4189-9907-2DE199A52E6A Q38344729-3838364B-14E0-477A-8E3E-2DC31A3D3B1D Q38778469-24E90321-87AD-436B-8665-1EEB55CE7E4D Q38841904-C3006B07-59DB-41BF-91A9-058A237E5D99 Q39021852-4DE4D775-897D-4A2A-AB5F-3C1C85601C80 Q41129373-B7B28ACC-ED79-43A7-9A2F-9F5CE90469FF Q41478234-4FDE854C-3371-4E13-8502-269EED413AD3 Q42105077-324F7503-F9BF-4A23-97E5-0FA528DDE9EC

P2860

Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11

http://www.wikidata.org/entity/Q35249810

description

2006 nî lūn-bûn

@nan

2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Inhibition of spontaneous brea ...... en monoclonal antibody JAA-F11

@ast

Inhibition of spontaneous brea ...... en monoclonal antibody JAA-F11

@en

type

label

Inhibition of spontaneous brea ...... en monoclonal antibody JAA-F11

@ast

Inhibition of spontaneous brea ...... en monoclonal antibody JAA-F11

@en

prefLabel

Inhibition of spontaneous brea ...... en monoclonal antibody JAA-F11

@ast

Inhibition of spontaneous brea ...... en monoclonal antibody JAA-F11

@en

P1433

Q35249810-51285C44-0797-4E98-88C4-C353A902C618

P1476

Q35249810-27AFA75A-133B-4FB7-97FC-64931D3BC315

P2093

Q35249810-015B64E0-61EE-43B1-9C4F-C9EE1980F49F

Q35249810-38D88AEC-CC7C-45F2-BF68-4F7F40219C83

Q35249810-3D364FDC-80B6-4823-93E5-E1AC9344EEE9

Q35249810-646D3777-0755-4424-BD39-A96980A74FB5

Q35249810-7937A13C-D78D-42FF-AF87-0106637111B0

Q35249810-C2080D52-89AD-4CC9-A4B2-CCC198D71613

Q35249810-C6A34B70-2A5B-4D28-A8F4-FA1DD4013F99

Q35249810-DFA6FC3B-81E9-4504-A4AB-2D26FE0D782C

P2860

Q35249810-05241E4F-5257-4ED0-A522-4FD98BAE6383

Q35249810-06D6F779-F163-48D3-A260-EA4752688228

Q35249810-21D7CB9E-8FAE-462D-B2DD-69B13A04E3C8

Q35249810-231B8961-8AF5-40CB-A7BF-0E2A68A51BF5

Q35249810-240EC9B1-7353-42B0-8326-6D3F95FB6500

Q35249810-245E78CD-A829-4563-AE1D-E914DCFB436D

Q35249810-2830AAC0-A1B2-462A-8157-75E70CBA60AF

Q35249810-2F07BBAD-5396-4F47-8DBF-A4724302B602

Q35249810-340E85B9-D20D-4A4B-925B-5CE1A5EBD459

Q35249810-3449E257-F319-4F29-9CA7-0481E57524FD

P304

Q35249810-51349B74-BA0A-459B-89CD-7736863E7DBD

P31

Q35249810-FCB85B9F-0CF9-478A-BD9C-065CCB38515C

P356

Q35249810-CEA865DF-7E48-447F-A560-0A13EE1E731D

P433

Q35249810-F77C42A5-184D-4244-9FDD-8AB61CE718F6

P478

Q35249810-AFA7A3D0-B320-42C4-9509-C1D95BDCF291

P50

Q35249810-73ACEA08-4AA7-44C2-96C6-20B653F6B036

Q35249810-E1E9E42E-7D66-4602-B849-E10364AEB37E

P577

Q35249810-C2257DE6-0CCB-4C00-BAAC-04CF9EBD358D

P5875

Q35249810-AD31BFBB-ABE4-48E6-975D-E85C16293300

P698

Q35249810-DFE2748F-A56C-401D-9D43-12120837BA00

P921

Q35249810-C1F39987-0571-4412-9903-2B8670FA90CA

P932

Q35249810-B8B15EEE-163D-43C8-915B-721A85F3A6F3

P356

P1433

P1476

Inhibition of spontaneous brea ...... en monoclonal antibody JAA-F11

@en

P2093

Jamie Heimburg

http://www.w3.org/2001/XMLSchema#string

Jun Yan

http://www.w3.org/2001/XMLSchema#string

Linda Wild

http://www.w3.org/2001/XMLSchema#string

Olga V Glinskii

http://www.w3.org/2001/XMLSchema#string

Rene Roy

http://www.w3.org/2001/XMLSchema#string

Robert Klick

http://www.w3.org/2001/XMLSchema#string

Susan Morey

http://www.w3.org/2001/XMLSchema#string

Virginia H Huxley

http://www.w3.org/2001/XMLSchema#string

P2860

The role of the Thomsen-Friedenreich antigen as a tumor-associated molecule

Synergistic cytotoxicity of iodine-131-anti-CD20 monoclonal antibodies and chemotherapy for treatment of B-cell lymphomas

Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells.

Opposite effects on human colon cancer cell proliferation of two dietary Thomsen-Friedenreich antigen-binding lectins.

Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor.

Specificity of reagents directed to the Thomsen-Friedenreich antigen and their capacity to bind to the surface of human carcinoma cell lines.

Theratope vaccine (STn-KLH).

Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trial

Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs.

Regulation of cellular homeostasis by galectins.

P304

939-948

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/NEO.06493

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Kate Rittenhouse-Olson

Vladislav V. Glinsky

P577

2006-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6666815

http://www.w3.org/2001/XMLSchema#string

P698

17132226

http://www.w3.org/2001/XMLSchema#string

P921

P932

1716011

http://www.w3.org/2001/XMLSchema#string